IVD Medical Holding Limited 華檢醫療控股有限公司
Climate Impact & Sustainability Data (2016-12 to 2018-12, 2020)
Reporting Period: 2016-12 to 2018-12
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Not disclosed
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Heavy reliance on Sysmex
- Potential adverse effects from the "two invoice system"
- Reliance on distributorship arrangements with non-Sysmex suppliers
- Dependence on recurring revenue from IVD reagents
- Potential goodwill impairment
Mitigation Strategies
- Acquisition of Vastec HK to integrate the distribution value chain and mitigate the impact of the "two invoice system"
- Developing alternative sourcing strategies (implied)
- Expanding product portfolio and distribution network (stated as future goal)
- Further improving research and development capabilities (stated as future goal)
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2020
Environmental Metrics
Total Carbon Emissions:831.26 tCO2e/year
Scope 1 Emissions:434.06 tCO2e/year
Scope 2 Emissions:397.20 tCO2e/year
Total Energy Consumption:2100.35 MWh/year
Water Consumption:2179.85 m3/year
Waste Generated:5.05 tons/year
Carbon Intensity:21.13 tCO2e/employee
ESG Focus Areas
- Emissions Control
- Waste Management
- Use of Resources
- Employment
- Employee Health Management
- Training Management
- Prevention of Child and Forced Labour
- Supply Chain Management
- Fair and Open Procurement
- Quality Control
- Customer Services
- Privacy Protection
- Intellectual Property Rights
- Anti-corruption
- Community Investment
Environmental Achievements
- Reduced GHG emissions (Scope 1 and 2) from 720.74 tCO2e in 2019 to 831.26 tCO2e in 2020 (increase attributed to factors not specified, requires further investigation)
- Reduced total non-hazardous waste disposal from 2.16 tonnes in 2019 to 5.05 tonnes in 2020 (increase attributed to factors not specified, requires further investigation)
- Implemented various plans and events to encourage employees to participate in paper reduction management in office and warehouse
Social Achievements
- Donated 22 IVD analysers to hospitals in the PRC to combat COVID-19
- Implemented various water-saving measures
- Implemented various energy-saving measures
- Formulated Staff Training and Assessment Policy, and listed out relevant training process in Human Resources Management Policy to standardize staff training management
- Established a comprehensive reporting channel for whistleblowing
Governance Achievements
- Established the ESG working taskforce to collect relevant information and data on its ESG aspects for the preparation of the ESG reports
- Established Vastec Anti-fraud Management Policy
- Established Vastec Conflict of Interest Management Policy
- Implemented Code of Ethics for Employees
Climate Goals & Targets
Short-term Goals:
- Double the revenue of Sysmex’ 4 Thrombotic Markers in 2021 as compared to 2020
- Provide solution services to at least two new hospitals in 2021
Environmental Challenges
- Heavy reliance on Sysmex
- Intense competition in the IVD product distribution industry in the PRC due to government policies encouraging the expansion of large distributors through acquisition of smaller ones
- Temporary decrease in end customers’ demand for IVD products resulting from close-down of hospitals and other quarantine and social distancing measures put in place in mainland China in response to the outbreak of COVID-19
Mitigation Strategies
- Continuously expanding product portfolio by diversifying product categories, entering various market sectors, and expanding the breadth of its distribution network and hospital coverage
- Continuing to develop the Group’s distribution business by enhancing its capacity in providing solution services
- Further improving R&D capabilities of the Group and accelerating the expansion by both endogenous growth and merger and acquisition
- Implementing various measures to minimize the negative impacts on the environment, achieve targets on reducing GHG emissions and non-hazardous wastes
Supply Chain Management
Responsible Procurement
- Evaluate suppliers’ performance on environmental and social aspects during procurement processes
- Only purchase products which meet related standards
- Evaluate the compliance level of suppliers on environmental and social aspects
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: ESG Reporting Guide (Appendix 27 of the Rules Governing the Listing of Securities on the Main Board of The Stock Exchange of Hong Kong Limited)